Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;6(4):576-585.
doi: 10.1086/688879.

Pulmonary pulse wave transit time is associated with right ventricular-pulmonary artery coupling in pulmonary arterial hypertension

Affiliations

Pulmonary pulse wave transit time is associated with right ventricular-pulmonary artery coupling in pulmonary arterial hypertension

Kurt W Prins et al. Pulm Circ. 2016 Dec.

Abstract

Pulmonary pulse wave transit time (pPTT), defined as the time for the systolic pressure pulse wave to travel from the pulmonary valve to the pulmonary veins, has been reported to be reduced in pulmonary arterial hypertension (PAH); however, the underlying mechanism of reduced pPTT is unknown. Here, we investigate the hypothesis that abbreviated pPTT in PAH results from impaired right ventricular-pulmonary artery (RV-PA) coupling. We quantified pPTT using pulsed-wave Doppler ultrasound from 10 healthy age- and sex-matched controls and 36 patients with PAH. pPTT was reduced in patients with PAH compared with controls. Univariate analysis revealed the following significant predictors of reduced pPTT: age, right ventricular fractional area change (RV FAC), tricuspid annular plane excursion (TAPSE), pulmonary arterial pressures (PAP), diastolic pulmonary gradient, transpulmonary gradient, pulmonary vascular resistance, and RV-PA coupling (defined as RV FAC/mean PAP or TAPSE/mean PAP). Although the correlations between pPTT and invasive markers of pulmonary vascular disease were modest, RV FAC (r = 0.64, P < 0.0001), TAPSE (r = 0.67, P < 0.0001), and RV-PA coupling (RV FAC/mean PAP: r = 0.72, P < 0.0001; TAPSE/mean PAP: r = 0.74, P < 0.0001) had the strongest relationships with pPTT. On multivariable analysis, only RV FAC, TAPSE, and RV-PA coupling were independent predictors of pPTT. We conclude that shortening of pPTT in patients with PAH results from altered RV-PA coupling, probably occurring as a result of reduced pulmonary arterial compliance. Thus, pPTT allows noninvasive determination of the status of both the pulmonary vasculature and the response of the RV in patients with PAH, thereby allowing monitoring of disease progression and regression.

Keywords: echocardiography; pulse wave velocity; right ventricular–pulmonary artery coupling.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Reduced pulmonary pulse wave transit time (pPTT) in patients with pulmonary arterial hypertension (PAH) determined using echocardiography. Shown are examples of determination of pPTT from a control patient (A) and a patient with PAH (B). Pulse wave Doppler interrogation of right ventricular outflow track (RVOT; upper boxes) and pulmonary veins (PVs; lower boxes). C, Quantification of pPTT (mean ± standard error of the mean) from 10 control patients and 36 patients with PAH. Asterisk indicates P < 0.0001. R-PVs2: time interval between the R-wave in the electrocardiogram and the corresponding peak late-systolic PV flow velocity; R-RVOT: time interval between the R-wave in the electrocardiogram and the corresponding onset of RVOT pulse Doppler flow velocity.
Figure 2
Figure 2
Distribution of pulmonary pulse transit time (pPTT) in controls and patients with pulmonary arterial hypertension (PAH). Most patients with PAH had lower pPTT when compared with the median pPTT of the age- and sex-matched control group. pPTT in the X-axis has no units, because it is normalized to the cardiac cycle length in seconds using the formula (time from R-wave to peak S-wave on pulmonary vein Doppler − time from R-wave to onset of right ventricular outflow track Doppler)/cardiac cycle length.
Figure 3
Figure 3
Moderate correlation between pulmonary pulse transit time (pPTT) and invasively measured markers of pulmonary vascular disease. Scatterplots showing moderate negative correlations between pPTT and diastolic pulmonary gradient (DPG; r = −0.61, P = 0.0002; Fig. 3A), transpulmonary gradient (TPG; r = −0.55, P = 0.001; Fig. 3B), pulmonary vascular resistance (PVR; r = −0.38, P = 0.04; Fig. 3C), and mean pulmonary arterial pressure (mPAP; r = −0.45, P = 0.006; Fig. 3D).
Figure 4
Figure 4
Pulmonary pulse transit time (pPTT) is most strongly associated with markers of right ventricular–pulmonary artery (RV-PA) coupling in pulmonary arterial hypertension (PAH). Scatterplots showing correlation between pPTT and right ventricular fractional area change (RV FAC; r = 0.64, P < 0.0001; Fig. 4A), tricuspid annular plane systolic excursion (TAPSE; r = 0.64, P < 0.0001; Fig. 4B), RV-PA coupling as defined by RV FAC/mean pulmonary arterial pressure (mPAP; r = 0.72, P < 0.0001; Fig. 4C), and RV-PA coupling as defined by TAPSE/mPAP (r = 0.74, P < 0.0001).
Figure 5
Figure 5
Forest plot of multivariate analysis of pulmonary pulse transit time (pPTT) in pulmonary arterial hypertension (PAH). Right ventricular fractional area change (RVFAC; A), tricuspid annular plane systolic excursion (TAPSE; B), and RV-PA coupling defined as RV FAC/mean pulmonary artery pressure (mPAP; C) and TAPSE/mPAP (D) were significantly associated with pPTT after correcting for pulmonary vascular resistance (PVR), diastolic pulmonary gradient (DPG), transpulmonary gradient (TPG), mPAP, presence of diabetes, and age. P values are listed to the right. Data are presented as coefficient with 95% confidence interval.
Figure S1
Figure S1
Method of pulmonary pulse wave transit time (pPTT) measurement. pPTT was calculated as time from R-wave to peak S-wave on pulmonary vein Doppler (R-PVs2) minus time from R-wave to onset of right ventricular outflow tract Doppler (R-RVOT) divided by cardiac cycle length. EKG: electrocardiogram.

References

    1. Rich JD, Rich S. Clinical diagnosis of pulmonary hypertension. Circulation 2014;130:1820–1830. - PubMed
    1. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013;62:D34–D41. - PubMed
    1. Thenappan T, Prins KW, Pritzker MR, Scandurra J, Volmers K, Weir EK. The critical role of pulmonary arterial compliance in pulmonary hypertension. Ann Am Thorac Soc 2016;13:276–284. - PMC - PubMed
    1. Saouti N, Westerhof N, Postmus PE, Vonk-Noordegraaf A. The arterial load in pulmonary hypertension. Eur Resp Rev 2010;19:197–203. - PMC - PubMed
    1. Tedford RJ. Determinants of right ventricular afterload (2013 Grover Conference series). Pulm Circ 2014;4:211–219. - PMC - PubMed

LinkOut - more resources